Wells Fargo Raises Globe Life (GL) Price Target to $191
Wells Fargo continues to favor Globe Life, setting a price target of $191, a 14.03% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Wells Fargo raised its price target on Globe Life Inc. ($GL) to $191 from $190 on October 12, 2026, and rates the stock "Overweight".
Since the rating, $GL is up 2.2% to date (from the $165.12 close on Oct 12, 2026).
GL
Globe Life Inc.
Key Points
- On October 12, 2026, Wells Fargo reiterated its Overweight rating on Globe Life Inc. with a new price target of $191, up from $190.
- Wells Fargo's $191 price target implies 14.03% upside from Globe Life Inc.'s ($GL) current $167.50 share price.
- The stock is currently trading around $167.5, which is about 12.3% below Wells Fargo's target.
- Globe Life has reported a trailing twelve-month revenue of approximately $6.19 billion and is scheduled to announce its next earnings on October 21, 2026.
Get $GL trade alerts by text
We text you when insiders, Congress or big funds trade $GL. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Globe Life Inc. alert may contain errors. Disclosures
Wells Fargo has reiterated its Overweight rating on Globe Life Inc. (NYSE: GL) as of October 12, 2026. The firm raised its price target slightly from $190 to $191, reflecting a positive outlook for the insurance company.
Wells Fargo vs. the S&P 500
Hypothetical returns from Wells Fargo's disclosed trades, not real profit or advice. How we model this.
Other Institutional Activity in Globe Life
Several other institutional investors have also been active with Globe Life shares. Invesco Ltd. grew its holdings by 602,856 shares, bringing its total to 4,619,219 shares worth about $779.4 million. Meanwhile, State Street Corporation increased its stake by 76,830 shares, ending with 3,735,409 shares valued at roughly $630.3 million. However, Blackrock Inc. and Vanguard Capital Management both reduced their positions, with decreases of 13,857 and 69,007 shares, respectively.
Globe Life Inc. Stock Down 3.4%
Currently, Globe Life shares are trading around $167.5, which positions them about 12.3% below the new price target set by Wells Fargo. This price is significant as it suggests the stock may have room to grow if it aligns with analysts' expectations.
$GL price target
Globe Life Inc. daily closes and this analyst's $191 target. Not advice.
Recent Earnings
Globe Life reported trailing twelve-month revenue of approximately $6.19 billion, with a net margin of 19.6% and a return on equity of 20.9%. The company's revenue growth year-over-year stands at 8%. Investors will be looking for further updates when the company announces its next earnings on October 21, 2026.
Insider Buying and Selling at Globe Life Inc.
Recent insider activity includes several notable sales. Michael Clay Majors, an Officer at Globe Life, sold 37,000 shares valued at about $6.61 million on July 29, 2026. Chief Financial Officer Thomas Peter Kalmbach sold 21,000 shares worth approximately $3.78 million the following day. Additionally, CEO James Matthew Darden sold 50,000 shares for around $9.12 million on July 31, 2026.
Analysts Set New Price Targets
On October 12, 2026, Wells Fargo maintained its Overweight rating on Globe Life Inc. with a price target of $191. Earlier, on October 5, Morgan Stanley also maintained an Overweight rating but adjusted its target down to $197. Other firms, like JP Morgan and TD Cowen, have recently set their targets at $195 and $225, respectively.
About Globe Life Inc.
Globe Life Inc. is based in McKinney, Texas, and provides life and supplemental health insurance products primarily to lower middle- and middle-income families in the United States. The company operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. With a workforce of approximately 3,695 employees, Globe Life continues to focus on expanding its market presence.
Bottom Line
Investors should watch for Globe Life's next earnings report on October 21, 2026, for further insights into its performance. The stock's current trading position below the analyst target may indicate potential for growth as the company continues to deliver on its business strategy.
Related Filing Alerts
Source: Wells Fargo's rating change on $GL (Oct 12, 2026). Written by software, not financial advice. How we make alerts